相关实验视频

Updated: May 22, 2025

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

在CDKL1和CDKL2中出现的新变异与神经发育症状有关

Ali H Bereshneh¹, Jonathan C Andrews¹, Daniel F Eberl²

¹Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, USA.

American journal of human genetics

|March 15, 2025

概括

新的研究确定了CDKL1和CDKL2基因的新变异,导致神经症状. 这些基因基因基因基因的基因变化导致发育性和性脑病,影响大脑功能.

科学领域:

遗传学是一个遗传学.
神经科学是一个神经科学.
分子生物学分子生物学

背景情况:

循环素依赖性酶类 (CDKL) 基因家族包括五个人类成员 (CDKL1-5),编码氨酸-氨酸酶.
已知CDKL5中的突变会导致发育性和性脑病变2型 (DEE2).
其他CDKL家族成员,特别是CDKL1和CDKL2在人类疾病中的作用仍然在很大程度上未被探索.

研究的目的:

研究CDKL1和CDKL2新型变异在患有发育障碍的人群中的作用.
使用Drosophila模型探索已识别的CDKL1和CDKL2变异的功能后果.
为了确定CDKL1和CDKL2变异是否通过主导负机制导致神经症状.

主要方法:

从患者队列中识别和分析CDKL1和CDKL2中的de novo变异.
使用Drosophila melanogaster模型与单个Cdkl ortolog.的变体的功能性表征.
通过在Drosophila模型中表达人类CDKL变异来评估基因救援和主导负效应.

主要成果:

在全球发育迟缓,智力障碍,,失常症和语言缺陷的个体中,在CDKL2中发现了四种de novo变异,在CDKL1中发现了两种变异.
德洛索菲拉Cdkl基因表现出与人类CDKL基因保持一致的功能,这是救援实验所证明的.
人类CDKL1和CDKL2变种未能完全拯救Drosophila中的Cdkl功能丧失表型,并表现出主导负效应,抑制野生类型人类CDKL基因的功能.

结论:

在CDKL1和CDKL2中,de novo变异与显著的神经现象有关,包括发育迟缓和.
鉴定到的变异可能会作为主导负等位基因,干扰野生类型CDKL蛋白的功能.
这些发现扩大了CDKL相关疾病的范围,并强调了CDKL1和CDKL2在神经发育中的重要性.

关键词:

在CDKL1中,CDKL1是在CDKL2中.在CDKL5中,CDKL5是 CG7236 这是一本书.Cdklkl 在线阅读这种植物是Drosophila.发育延迟的发展延迟.是一种.周围神经系统周围神经系统

更多相关视频

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

相关概念视频

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...